Tiny labs enhance rapid diagnostics
20.02.2025
Imagine a tiny lab fitting in your hand, delivering critical diagnoses within just one hour. The Molecular Mouse rapidly detects microorganisms and antibiotic resistance, enabling swift and precise treatment decisions. Meanwhile, the CLIA system enhances sensitivity, allows simultaneous disease testing, and automates workflows, making laboratories more efficient and responsive to urgent cases.
Point-of-care tests – the future of on-site diagnostics
11.11.2024
In our video tour from Hall 3 at MEDICA 2024, we talk to some manufacturers who specialize in these indispensable diagnostic tools.
The University of Texas at El Paso
Low-cost biochip for rapid cancer detection developed at UTEP
08.11.2024
A team at The University of Texas at El Paso, led by Dr. Xiujun Li, has developed a portable, low-cost device that detects colorectal and prostate cancer in under an hour. Designed for accessibility, this biochip could provide life-saving early detection for patients in rural and underserved areas.
Patrick Campbell/CU Boulder
A faster, easier way to test blood at the bedside with handheld device
23.10.2024
Researchers at the University of Colorado Boulder are developing a handheld device that uses sound waves to detect biomarkers from a finger-prick of blood. It delivers highly sensitive results in under 70 minutes, providing a faster and more accessible alternative to traditional lab-based tests. The research was published in Science Advances.
Sylvester Cancer
Mouthwash test for predicting head and neck cancer recurrence
18.10.2024
A study by researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, UC San Diego Health, and other collaborating centers suggests that a simple mouthwash-based test could help predict the recurrence of head and neck cancers.
Okos Diagnostics
From waste to sustainable wins: Rapid tests with biomaterials
27.08.2024
Over 2 billion rapid test (lateral flow assay) kits are produced every year, adding tens of thousands of tons of used materials to the growing global volume of medical waste. Every test kit contains around 12 grams of plastic and is designed for single use. The company Okos Diagnostics, founded in 2022, aims to reduce the waste with a sustainable rapid test solution.
SteveAllenPhoto999
DIANA: Alliance for innovative point-of-care tests
23.07.2024
To improve local medical care through point-of-care tests (PoCT), 80 partners from industry and research in Saxony and Thuringia have joined forces to form the DIANA (Diagnostics and Sustainability) alliance. Dr. Dirk Kuhlmeier coordinates the alliance.
Portable diagnostic device for early detection of deep vein thrombosis
19.06.2024
A new EU-funded project called ThrombUS+ aims to detect vein thrombosis at an early stage. Vein thrombosis poses a significant health risk, often occurring without symptoms and potentially leading to life-threatening pulmonary embolisms. The project is developing a portable solution that enables continuous monitoring and immediate detection.
Messe Düsseldorf/Andreas Wiese
World Laboratory Day: Laboratory medicine in transition
16.04.2024
World Laboratory Day takes place annually on April 23. It is intended to draw attention to the work in laboratories and the achievements of laboratory employees. MEDICA-tradefair.com takes the day as an opportunity to highlight current trends that continue to shape these work environments. These trends will also be a main focus of the MEDICA LABMED FORUM at MEDICA 2024.
Raman sensor system: non-invasive monitoring with wide-ranging applications
04.04.2024
The Raman sensor system opens new monitoring possibilities by precisely measuring the concentration of carotenoids in the skin - a potential indicator of health. This technology offers a non-invasive insight into dietary habits and health status, with the potential to monitor the effectiveness of chemotherapies.
EU-Funded Project PAIR improves pandemic preparedness
08.02.2024
The EU-funded project PAIR has just started in Copenhagen with the participation of 20 partners from seven countries. This five-year project aims to ensure that Europe possesses the expertise and capabilities for advanced point-of-care systems and prognostic models based on artificial intelligence and machine learning.
djoronimo
Pre-eclampsia diagnosis in focus: MOMM Diagnostics' rapid test
22.12.2023
Early diagnosis is crucial in the case of pregnancy toxemia or pre-eclampsia. The young company MOMM Diagnostics is developing a diagnostic tool to help detect pre-eclampsia quickly and accurately. The start-up was already able to present an initial prototype of préXclude at MEDICA 2023. Clinical trials are due to start soon.
eHealth, mHealth, AI, and much more – Highlight tour in the MEDICA START-UP PARK
13.11.2023
Every year, the MEDICA START-UP PARK attracts a lot of visitors. Young, up-and-coming companies present their products here – often for the first time ever. This stand has already been the starting point for the success stories of some companies that are now internationally active. At MEDICA 2023, we are once again taking the opportunity to talk to promising start-ups.
Brandon Martin/Rice University
Affordable global health technologies for early cancer detection
06.11.2023
A Rice University-led collaboration from three continents has won up to a five-year grant from the National Institutes of Health to establish a premier research center in the Texas Medical Center to develop affordable, effective point-of-care (POC) technologies that improve early cancer detection in low-resource settings in the United States and other countries.
InfectoGnostics
InfectoGnostics study: Benefits of on-site tests in general practices
05.09.2023
General practitioners (GP) regularly use on-site rapid tests because they find their application useful. However, frequent utilisation fails due to costs and remuneration regulations. These are the results of a study by InfectoGnostics researchers at the University Hospital Jena in the project "POCT-ambulant", in which 292 GPs in Thuringia, Bremen and Bavaria participated.
drazenphoto
Revolutionizing virus detection: the power of AI and CRISPR
04.07.2023
In the midst of the COVID-19 pandemic, scientists and researchers have been tirelessly working to develop innovative and accurate tests to identify the presence of viruses. One breakthrough technology that has emerged is the combination of artificial intelligence (AI) and CRISPR, which has revolutionized virus detection.
leungchopan
AI helps create better, simpler hepatitis, COVID-19 tests
11.05.2023
University of Florida scientists have used artificial intelligence tools to simplify a test that works for both hepatitis C and SARS-CoV-2, the virus that causes COVID-19. The simplified test happens in one small test tube in just a few minutes.
HZDR/Sandoval Bojorquez
Nanobiosensor developed for detecting SARS-CoV-2
04.04.2023
Infection and immunity status of the population are considered key parameters for handling pandemics. For this purpose, detecting antigens and antibodies is of great importance. The devices currently used for this purpose - what are known as point-of-care (POC) devices- are one option for rapid screening. Their sensitivity, however, needs further improvement.